Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
34 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Augenarzte Am St. Franziskus Hospital
Münster, Germany
- Universitatsklinikum Tubingen
Tübingen, Germany
- Bajcsy-Zsilinszky Kórház És Rendelőintézet
Budapest, Hungary
- L. V. Prasad Eye Institute - Hospital
Hyderabad, Andhra Pradesh, India
- L.V. Prasad Eye Institute
Patia, Bhubaneshwar, India
- C.H Nagri Municipal Eye Hospital
Ahmedabad, Gujarat, India
- Seth G.S. Medical College & Kem Hospital
Pārel, Mumbai, India
- Pbma'S H.V. Desai Eye Hospital
Hadapsar, Pune, India
- King George'S Medical University
Lucknow, Uttar Pradesh, India
- Hadassah University Hospital Ein Kerem
Jerusalem, Israel
- Rabin Medical Center
Petah Tikva, Israel
- Sheba Medical Center
Qiryat Ono, Israel
- Royal Hospitals Trust
Belfast, United Kingdom
- Birmingham and Midland Eye Centre
Birmingham, United Kingdom
- Bradford Royal Infirmary
Bradford, United Kingdom
- Gloucestershire Royal Hospital
Gloucester, United Kingdom
- Moorfields Eye Hospital
London, United Kingdom
- St Thomas Hospital
London, United Kingdom
- Retina Vitreaous Associates
Beverly Hills, California, United States
- Retinal Consultants Medical Group, Inc
Sacramento, California, United States
- Retina Macula Institute
Torrance, California, United States
- Retina Consultants of Southern Colorado
Colorado Springs, Colorado, United States
- Northwestern University
Chicago, Illinois, United States
- Ophthalmology & Visual Sciences
Lexington, Kentucky, United States
- Ocular Immunology and Uveitis Foundation
Cambridge, Massachusetts, United States
- University of Nebraska Medical Center
Omaha, Nebraska, United States
- Retina Consultants
Slingerlands, New York, United States
- Duke University Eye Center
Durham, North Carolina, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Ohsu Casey Eye Institute
Portland, Oregon, United States
- Charleston Neuroscience Institute
Ladson, South Carolina, United States
- Texas Retina Associates
Arlington, Texas, United States
- Retina Consultants of Houston
Houston, Texas, United States
- Foresight Studies, Llc
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 2 Aug 2013
- Primary completion
- 26 Mar 2018
- Completion
- 26 Mar 2018
- Last update posted
- 2 Apr 2021
- Registered enrollment
- 129
- Registry id
- NCT01694186
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.